Biomaterial Database

Complement levels in beta-thalassaemia major. 1973

B Seitanidis, and D Kremastinos, and B Angelopoulos

UI	MeSH Term	Description	Entries
D002648	Child	A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL.	Children
D003165	Complement System Proteins	Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY).	Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293	Adolescent	A person 13 to 18 years of age.	Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328	Adult	A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available.	Adults
D013789	Thalassemia	A group of hereditary hemolytic anemias in which there is decreased synthesis of one or more hemoglobin polypeptide chains. There are several genetic types with clinical pictures ranging from barely detectable hematologic abnormality to severe and fatal anemia.	Thalassemias

Related Publications

B Seitanidis, and D Kremastinos, and B Angelopoulos

Plasma homocysteine levels in patients with beta-thalassaemia major.

January 2008, Scandinavian journal of clinical and laboratory investigation,

B Seitanidis, and D Kremastinos, and B Angelopoulos

beta-Thalassaemia major in Kuwait.

October 1998, Journal of tropical pediatrics,

B Seitanidis, and D Kremastinos, and B Angelopoulos

Serum vitamin E levels with beta-thalassaemia major: preliminary report.

February 1974, British journal of haematology,

B Seitanidis, and D Kremastinos, and B Angelopoulos

Interleukins 12 and 13 levels among beta-thalassaemia major patients.

February 2013, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit,

B Seitanidis, and D Kremastinos, and B Angelopoulos

Iron overload and urinary lysosomal enzyme levels in beta-thalassaemia major.

August 1997, European journal of pediatrics,

B Seitanidis, and D Kremastinos, and B Angelopoulos

NT-proBNP levels and diastolic dysfunction in beta-thalassaemia major patients.

May 2007, European journal of heart failure,

B Seitanidis, and D Kremastinos, and B Angelopoulos

Cerebral thrombosis in beta-thalassaemia major.

November 2001, Indian journal of pediatrics,

B Seitanidis, and D Kremastinos, and B Angelopoulos

The kidney in beta-thalassaemia major.

January 1985, Acta haematologica,